gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots.
暂无分享,去创建一个
B. Jortner | R. LoPachin | Bernard S Jortner | M. Reid | Richard M LoPachin | Maria L Reid | Soma Das | Soma Das
[1] M. Abou‐Donia,et al. Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy , 1988, Brain Research.
[2] D. Anthony,et al. The Spatio‐Temporal Pattern of the Axonopathy Associated with the Neurotoxicity of 3,4‐Dimethyl-2,5‐Hexanedione in the Rat , 1983, Journal of neuropathology and experimental neurology.
[3] E. Lehning,et al. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper. , 1997, Neurotoxicology.
[4] J. Povlishock,et al. A mechanistic analysis of nondisruptive axonal injury: a review. , 1997, Journal of neurotrauma.
[5] S. Ochs,et al. The origin and nature of beading: A reversible transformation of the shape of nerve fibers , 1997, Progress in Neurobiology.
[6] G. Perry,et al. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Moretto,et al. Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro , 2005, Archives of Toxicology.
[8] P. Spencer,et al. Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. , 1976, Brain : a journal of neurology.
[9] T B Shea,et al. Microtubule motors, phosphorylation and axonal transport of neurofilaments , 2000, Journal of neurocytology.
[10] D. Ap. n-Hexane neurotoxicity: a mechanism involving pyrrole adduct formation in axonal cytoskeletal protein. , 1987 .
[11] P. Gambetti,et al. Hexacarbon axonopathy: the morphological expression of altered cytoskeletal translocation. , 1988 .
[12] P. Spencer,et al. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. , 1977, Journal of neuropathology and experimental neurology.
[13] T. Yokota,et al. Electrophysiological study of dorsal column function in streptozocin-induced diabetic rats: comparison with 2,5-hexanedione intoxication , 1993, Journal of the Neurological Sciences.
[14] S. Das,et al. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. , 2002, Neurotoxicology.
[15] G. Losos,et al. Comparison of Central and Peripheral Nervous System Lesions Caused by High-Dose Short-Term and Low-Dose Subchronic Acrylamide Treatment in Rats , 1986, Toxicologic pathology.
[16] E. Lehning,et al. γ-Diketone Peripheral Neuropathy: II. Neurofilament Subunit Content , 2000 .
[17] A. DeCaprio,et al. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat. , 1988, Toxicology and applied pharmacology.
[18] B. Jortner,et al. Biochemical and morphologic characterization of acrylamide peripheral neuropathy. , 1998, Toxicology and applied pharmacology.
[19] R. Mayer,et al. 2,5‐hexanedione‐induced intermediate filament aggregates contain ubiquitin‐protein conjugate immunoreactivity and resemble Rosenthal fibres , 1992, Neuropathology and applied neurobiology.
[20] H. Kretzschmar,et al. Giant axonal neuropathy , 1972, Acta Neuropathologica.
[21] N. Muma,et al. Neurofilaments are intrinsic determinants of axonal caliber , 1993 .
[22] A. DeCaprio. Molecular mechanisms of diketone neurotoxicity. , 1985, Chemico-biological interactions.
[23] E. Lehning,et al. γ-Diketone Peripheral Neuropathy: III. Neurofilament Gene Expression , 2001 .
[24] C. Wade,et al. Subchronic toxicity of acrylamide administered to rats in the drinking water followed by up to 144 days of recovery. , 1980, Journal of environmental pathology and toxicology.
[25] C. Balaban,et al. Acrylamide axonopathy revisited. , 2003, Toxicology and applied pharmacology.
[26] Y. Yagi. Effects of 2,5-hexanedione on rat spinal pyramidal tract. , 1994, Sangyo igaku. Japanese journal of industrial health.
[27] J. Eichberg,et al. Hexanedione effects on protein phosphorylation in rat peripheral nerve , 1989, Brain Research.
[28] E. Lehning,et al. Nerve terminals as the primary site of acrylamide action: a hypothesis. , 2002, Neurotoxicology.
[29] E. A. O'neill,et al. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. , 1985, Toxicology and applied pharmacology.
[30] R. Nixon,et al. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber , 1994, The Journal of cell biology.
[31] B. Jortner,et al. Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy. , 2000, Toxicology and applied pharmacology.
[32] G. Divincenzo,et al. The enlarging view of hexacarbon neurotoxicity. , 1980, Critical reviews in toxicology.
[33] R. Anderson,et al. Electrophysiologic deficits in peripheral nerve as a discriminator of early hexacarbon neurotoxicity. , 1984, Journal of toxicology and environmental health.
[34] A. DeCaprio,et al. Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein. , 1994, Chemical research in toxicology.
[35] J. Cavanagh,et al. Distortions of the nodes of Ranvier from axonal distension by filamentous masses in hexacarbon intoxication , 1983, Journal of neurocytology.
[36] E. Lehning,et al. Mechanism of calcium entry during axon injury and degeneration. , 1997, Toxicology and applied pharmacology.
[37] N. Strominger,et al. Neurotoxicity and protein binding of 2,5-hexanedione in the hen. , 1983, Toxicology and applied pharmacology.
[38] R. Nixon,et al. Multiple phosphorylated variants of the high molecular mass subunit of neurofilaments in axons of retinal cell neurons: characterization and evidence for their differential association with stationary and moving neurofilaments , 1988, The Journal of cell biology.
[39] G. Divincenzo,et al. The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. , 1980, Toxicology and applied pharmacology.
[40] J. L. Gill,et al. Design and analysis of experiments in the animal and medical sciences , 1980 .
[41] T. Sakaguchi,et al. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail , 1993, Neuroscience Letters.
[42] P. Spencer,et al. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. , 1977, Journal of neuropathology and experimental neurology.
[43] D. Anthony,et al. dl- versus meso-3,4-dimethyl-2,5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat. , 1987, Toxicology and applied pharmacology.
[44] L. Autilio‐Gambetti,et al. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport , 1990, Brain Research.
[45] L. Autilio‐Gambetti,et al. Experimental Increase of Neurofilament Transport Rate: Decreases in Neurofilament Number and in Axon Diameter , 1989, Journal of neuropathology and experimental neurology.
[46] D. Anthony,et al. Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy. , 1988, Chemical research in toxicology.
[47] W. Schlaepfer,et al. 2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins. , 1986, Neurochemical pathology.
[48] D. Anthony,et al. Decreased levels of the high molecular weight subunit of neurofilaments and accelerated neurofilament transport during the recovery phase of 2,5-hexanedione exposure. , 1993, Cell motility and the cytoskeleton.
[49] A. DeCaprio,et al. Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro. , 1997, Toxicology and applied pharmacology.
[50] K. Boekelheide,et al. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings. , 1983, Toxicology and applied pharmacology.
[51] K. Haglid,et al. Quantitative and Qualitative Alterations of Neuronal and Glial Intermediate Filaments in Rat Nervous System After Exposure to 2, 5‐Hexanedione , 1991, Journal of neurochemistry.
[52] R. Stein,et al. The relationship between axon diameter, myelin thickness and conduction velocity during atrophy of mammalian peripheral nerves , 1983, Brain Research.
[53] M. Ehrich,et al. Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing. , 2001, Neurotoxicology.
[54] D. Couri,et al. Biophysical and electrophysiological studies of hexanedione neurotoxicity. , 1981, Neurotoxicology.
[55] J. Griffin,et al. Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication , 1991, Brain Research.
[56] T. Fujii,et al. Neurotoxic effects of 2,5-hexanedione on rapidly growing unmyelinated peripheral nerve axons of a rat fetus: dose-effect relationship. , 1993, Environmental research.
[57] K. Boekelheide,et al. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. , 1982, Toxicology and applied pharmacology.
[58] John A. Wolf,et al. High Tolerance and Delayed Elastic Response of Cultured Axons to Dynamic Stretch Injury , 1999, The Journal of Neuroscience.
[59] A. Ludolph,et al. Experimental and clinical neurotoxicology , 1980 .
[60] B. Jortner,et al. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. , 1995, Toxicology and applied pharmacology.
[61] S. Yoshimura,et al. The same chemicals induce different neurotoxicity when administered in high doses for short term or low doses for long term to rats and dogs. , 1992, Molecular and chemical neuropathology.
[62] E. Lehning,et al. 2,5‐Hexanedione Alters Elemental Composition and Water Content of Rat Peripheral Nerve Myelinated Axons , 1994, Journal of neurochemistry.
[63] J. Fraher. A quantitative study of anterior root fibres during early myelination. , 1972, Journal of anatomy.
[64] D. Cleveland,et al. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. , 1994, Current opinion in cell biology.
[65] L. Autilio‐Gambetti,et al. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication , 1989, Brain Research.
[66] D. Anthony,et al. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. , 1995, Critical reviews in toxicology.
[67] J. Cavanagh,et al. THE EARLY EVOLUTION OF NEUROFILAMENTOUS ACCUMULATIONS DUE TO 2,5‐HEXANEDIOL IN THE OPTIC PATHWAYS OF THE RAT , 1982, Neuropathology and applied neurobiology.
[68] L. Autilio‐Gambetti,et al. Giant axonal neuropathy: acceleration of neurofilament transport in optic axons. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[69] R. Irwin,et al. Cross‐Linking of Neurofilament Proteins of Rat Spinal Cord In Vivo After Administration of 2,5‐Hexanedione , 1986, Journal of neurochemistry.
[70] J. Arezzo,et al. gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling. , 2000, Toxicology and Applied Pharmacology.